Dobbie LJ, Cuthbertson DJ, Hydes TJ, Alam U, et al. Mendelian randomisation reveals Sodium-glucose Cotransporter-1 inhibition's potential in reducing Non-Alcoholic Fatty Liver Disease risk. Eur J Endocrinol 2023;188:K33-K37.
PMID: 37343141